Current:Home > StocksAn appeals court has revived a challenge to President Biden’s Medicare drug price reduction program -TradeWise
An appeals court has revived a challenge to President Biden’s Medicare drug price reduction program
View
Date:2025-04-12 19:40:09
NEW ORLEANS (AP) — A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used prescription drugs was revived by a federal appeals court in New Orleans in a 2-1 decision Friday.
Congress created the program as part of the Inflation Reduction Act passed in 2022. The first 10 drugs targeted for negotiations were announced last year, and new prices, agreed upon last month, are set to take effect in 2026.
Friday’s ruling was handed down by the 5th U.S. Circuit Court of Appeals. It does not derail the program, but the ruling sends the case back for further consideration by the Texas-based federal district court that tossed it in February. And it means the case is likely to wind up back before the conservative-dominated appeals court where opponents of President Joe Biden’s initiatives often pursue challenges on issues ranging from abortion access to immigration to gun rights..
The lead plaintiff in the lawsuit is the National Infusion Center Association, which filed as a representative of the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Global Colon Cancer Association.
Among their arguments is that Congress lacked constitutional authority to delegate Medicare pricing authority to an executive branch department.
The district court said the federal Medicare Act requires such claims to first be channeled through the Department of Health and Human Services. But 5th Circuit Judge Jennifer Walker Elrod wrote that the claim was brought under the IRA, not the Medicare Act. Elrod, who was nominated to the 5th Circuit by former President George W. Bush, wrote on behalf of herself and Judge Kyle Duncan, nominated by former President Donald Trump.
In a dissent, Judge Irma Ramirez, nominated by President Joe Biden, said the lawsuit was properly dismissed and that the Medicare Act “provides the standing and substantive basis” of the National Infusion Center Association’s claims.
The Department of Health and Human Services declined comment.
PhRMA released a statement applauding the ruling: “We are pleased the Fifth Circuit agreed that the merits of our lawsuit challenging the IRA’s drug pricing provisions should be heard.”
The advocacy group AARP was critical of the lawsuit. “Any efforts to stop the drug negotiation program in its tracks risks the wellbeing of millions of older adults in the country who have waited far too long to afford medicine,” the organization said in an emailed release.
veryGood! (3)
Related
- Former Danish minister for Greenland discusses Trump's push to acquire island
- Microsoft slashes 10,000 jobs, the latest in a wave of layoffs
- Rihanna Has Love on the Brain After A$AP Rocky Shares New Photos of Their Baby Boy RZA
- 3 dead, multiple people hurt in Greyhound bus crash on Illinois interstate highway ramp
- Head of the Federal Aviation Administration to resign, allowing Trump to pick his successor
- Suspect arrested in Cleveland shooting that wounded 9
- Powerball jackpot grows to $725 million, 7th largest ever
- Lisa Marie Presley’s Twins Finley and Harper Lockwood Look So Grown Up in Graduation Photo
- The Louvre will be renovated and the 'Mona Lisa' will have her own room
- 8 Simple Hacks to Prevent Chafing
Ranking
- Highlights from Trump’s interview with Time magazine
- World Talks on a Treaty to Control Plastic Pollution Are Set for Nairobi in February. How To Do So Is Still Up in the Air
- The South’s Communication Infrastructure Can’t Withstand Climate Change
- Inside Clean Energy: Rooftop Solar Wins Big in Kansas Court Ruling
- Paula Abdul settles lawsuit with former 'So You Think You Can Dance' co
- The Senate's Ticketmaster hearing featured plenty of Taylor Swift puns and protesters
- This 22-year-old is trying to save us from ChatGPT before it changes writing forever
- House GOP chair accuses HHS of changing their story on NIH reappointments snafu
Recommendation
Pressure on a veteran and senator shows what’s next for those who oppose Trump
Inside Clean Energy: At a Critical Moment, the Coronavirus Threatens to Bring Offshore Wind to a Halt
Deer spread COVID to humans multiple times, new research suggests
On California’s Coast, Black Abalone, Already Vulnerable to Climate Change, are Increasingly Threatened by Wildfire
Man can't find second winning lottery ticket, sues over $394 million jackpot, lawsuit says
Will 2021 Be the Year for Environmental Justice Legislation? States Are Already Leading the Way
Billion-Dollar Disasters: The Costs, in Lives and Dollars, Have Never Been So High
UN Report: Despite Falling Energy Demand, Governments Set on Increasing Fossil Fuel Production